Search Results 61-70 of 16859 for Lou Gehrig's disease
... ALS research. Through comparison of these samples, the researchers hope to learn more about the underlying cause of ALS ... disease, and previous treatments or ...
... ALS/FTD to characterize pre-symptomatic ALS/FTD disease states. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...
Sandra's story of living with Lou Gehrig's disease featured image. Sandra's story of living with Lou Gehrig's disease. Cynthia Weiss. December 30, 2019.
Protein Test is First to Predict Rate of Progression in Lou Gehrig's Disease. mayonewsreleases. November 19, 2012. Could a 'Brain Pacemaker' Stop Epileptic ...
The primary objective of the study is to evaluate the long-term safety and tolerability of BIIB067 in participants with amyotrophic lateral sclerosis (ALS) and ...
The samples will be used in future research to learn about how these disorders affect people, what causes these conditions, and how the investigators can tell ...
Maximum inspiratory pressure and overnight pulse oximetry abnormalities occurred earlier, approximately 1.8 and 2.0 years after disease manifestation in ...
Mayo Clinic Q and A: Understanding binge eating disorder featured image · Sandra's story of living with Lou Gehrig's disease featured image · Infectious Diseases ...
More recently, the lab's neuropathologic research has focused on ALS, which also is known as Lou Gehrig's disease, and frontotemporal degeneration with TDP-43 ...
Edaravone is used to treat patients with amyotrophic lateral sclerosis (ALS), which is also known as Lou Gehrig's disease. This medicine is available only ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 31 to multiply your impact 3×.